Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-031760

General Counsel sold 12,109 shares at $3.02 ($36,557)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-08-14 Sale : show line 1 in the form −12,109 $3.02 $36,557 137,054 D
Open-market sales · 12,109 sh · avg $3.02 · $36,557
Loading xslF345X05/form4.xml…